Lilly/Icos Cialis Outpaces Bayer/GSK Levitra With 18% Share Of New Scripts
This article was originally published in The Pink Sheet Daily
Executive Summary
Cialis has tracked ahead of Levitra for “three weeks running,” Lilly reports. Both agents are in a head-to-head battle to overtake the market leader, Pfizer’s Viagra.
You may also be interested in...
Levitra Market Share Hurt By Lack of Branded Ads At Launch, GSK Says
GSK and Bayer were hesitant to launch Levitra with full product ads because of risk info, but the Cialis branded campaign revealed consumers were not dissuaded by product risks, GSK says. Sampling and internet sales of counterfeits have slowed growth in the category.
Levitra Market Share Hurt By Lack of Branded Ads At Launch, GSK Says
GSK and Bayer were hesitant to launch Levitra with full product ads because of risk info, but the Cialis branded campaign revealed consumers were not dissuaded by product risks, GSK says. Sampling and internet sales of counterfeits have slowed growth in the category.
Pfizer Viagra "Value Card" Offers Buy-Six-Get-One-Free Script Deal
The card program is available to patients who either pay out of pocket for Viagra or receive partial third-party coverage. Pfizer will dedicate full print and radio ads to the Value Card and update current TV commercials.